Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Form 8.3 - CBP LN

15 Sep 2023 16:18

RNS Number : 6617M
Syquant Capital
15 September 2023
 

Table

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Curtis Bank Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

September 7, 2023

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,230,000

1.83%

 

 

(2) Derivatives (other than options):

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

1,230,000

1.83%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p ordinary

5p ordinary

 

CFD

CFD

 

increasing a long position

increasing a long position

 

230,000

1,000,000

 

347.5 GBp

347 GBp

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

September 15, 2023

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETNKPBDPBKDQCD
Date   Source Headline
1st Dec 202212:58 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
1st Dec 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
1st Dec 20229:32 amRNSForm 8.5 (EPT/RI)
30th Nov 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Bank Plc
30th Nov 202210:48 amRNSForm 8.5 (EPT/RI)
29th Nov 20225:12 pmRNSForm 8.3 - Curtis Banks Group plc
29th Nov 20221:17 pmGNWForm 8.3 - Octopus Investments - Curtis Banks Group plc
29th Nov 202212:00 pmRNSForm 8.5 (EPT/RI) - Curtis Bank Plc
29th Nov 20229:23 amRNSForm 8.3 - Curtis Banks Group plc
29th Nov 20229:10 amRNSForm 8.5 (EPT/RI)
28th Nov 20223:17 pmRNSForm 8.3 - Curtis Banks Group Plc
28th Nov 20222:26 pmRNSForm 8.3 - Curtis Banks Group Plc
28th Nov 20221:41 pmRNSForm 8.3 - Curtis Banks Group plc
28th Nov 20221:36 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Curtis Banks Group plc
28th Nov 20221:18 pmGNWForm 8.3 - Form 8.3 - Octopus Investments - Curtis Banks Group plc
28th Nov 202212:11 pmRNSForm 8.5 (EPT/RI) - Curtis Banks Plc
28th Nov 202210:44 amGNWRule 8.3 - [CURTIS BANKS GROUP PLC - 25 11 2022 - Opening Declaration] - (CGAML)
28th Nov 202210:23 amRNSForm 8.5 (EPT/RI)
28th Nov 20228:49 amRNSForm 8.3 - [Curtis Banks Group PLC]
25th Nov 20221:33 pmRNSStatement Regarding Curtis Banks Group PLC
25th Nov 20221:08 pmRNSForm 8.3 - Curtis Banks Group PLC
25th Nov 202211:41 amRNSStatement re Possible Offer
21st Nov 20224:50 pmRNSBoard changes
10th Nov 20226:20 pmRNSDirector Declaration
7th Oct 20225:36 pmRNSChairman's incentive plan
5th Oct 20221:50 pmRNSHolding(s) in Company
20th Sep 20227:00 amRNSDividend Timetable
8th Sep 20227:00 amRNSInterim Results
9th Aug 20227:00 amRNSDirectorate Change
20th Jul 20224:36 pmRNSPrice Monitoring Extension
1st Jul 20225:05 pmRNSDirector/PDMR Shareholding
17th Jun 20227:00 amRNSDirectorate Change
9th Jun 20224:48 pmRNSDirector/PDMR Shareholding
7th Jun 20222:38 pmRNSHolding(s) in Company
26th May 20226:37 pmRNSResult of AGM - CORRECTION
26th May 20224:30 pmRNSResult of Annual General Meeting
26th May 20227:00 amRNSAGM and Board appointments
29th Apr 20227:00 amRNSNotice of AGM
20th Apr 20225:27 pmRNSDirector/PDMR Shareholding
13th Apr 20224:42 pmRNSDirector/PDMR Dealing
31st Mar 20227:17 amRNSFinal Results
8th Feb 20225:28 pmRNSHolding(s) in Company
29th Dec 20217:00 amRNSHolding(s) in Company
24th Dec 202112:41 pmRNSSecond Price Monitoring Extn
24th Dec 202112:35 pmRNSPrice Monitoring Extension
17th Nov 20217:00 amRNSHolding(s) in Company
12th Nov 20214:41 pmRNSSecond Price Monitoring Extn
12th Nov 20214:36 pmRNSPrice Monitoring Extension
9th Nov 20214:41 pmRNSSecond Price Monitoring Extn
9th Nov 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.